SCHEMBL7183015

SCHEMBL7183015

CC(=O)OC[C@@H](C)Nc1ccc(C#N)cc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
CACNA1F O60840 1/20 0.38
CACNA1D Q01668 1/20 0.38
CACNA1S Q13698 1/20 0.38
CACNA1C Q13936 1/20 0.38
ABCC9 O60706 1/20 0.37
ABCC8 Q09428 1/20 0.37
KCNJ11 Q14654 1/20 0.37
KCNJ8 Q15842 1/20 0.37
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185647 1.00 KDM4E (0.44) KDM4EALDH1A1GAAADRB2ADRB1
SCHEMBL7190795 0.85 GAA (0.39) KDM4EALDH1A1GAAADRB2ADRB1
SCHEMBL7188673 0.85 GAA (0.39) KDM4EALDH1A1GAAADRB2ADRB1
SCHEMBL7190961 0.81 HCAR3 (0.53) ALDH1A1KMT2ATDP1HCAR3
SCHEMBL7184178 0.81 HCAR3 (0.53) ALDH1A1KMT2ATDP1HCAR3
SCHEMBL7185261 0.80 KDM4E (0.48) KDM4EALDH1A1GAAABCC9ABCC8
SCHEMBL7179367 0.80 KDM4E (0.48) KDM4EALDH1A1GAAABCC9ABCC8
SCHEMBL7182989 0.78 MAPK8 (0.38) PRKD3MAPK8MAP4K4MINK1TNIK
SCHEMBL7183531 0.75 ALDH1A1 (0.41) KDM4EALDH1A1GAAABCC9ABCC8
SCHEMBL7191231 0.75 PTGER4 (0.48) KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6582351-B1 Benzimidazole heterocyclic compounds having pharmacological activities, and their use as a medicament for treatment or prevention of diseases mediated by cGMP-PDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-24 US disclosed